151 related articles for article (PubMed ID: 8603484)
1. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Hirose M; Hasegawa R; Kimura J; Akagi K; Yoshida Y; Tanaka H; Miki T; Satoh T; Wakabayashi K; Ito N
Carcinogenesis; 1995 Dec; 16(12):3049-55. PubMed ID: 8603484
[TBL] [Abstract][Full Text] [Related]
2. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments.
Hirose M; Futakuchi M; Tanaka H; Orita SI; Ito T; Miki T; Shirai T
Eur J Cancer Prev; 1998 Feb; 7(1):61-7. PubMed ID: 9511852
[TBL] [Abstract][Full Text] [Related]
3. Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis.
Hirose M; Takahashi S; Ogawa K; Futakuchi M; Shirai T
Food Chem Toxicol; 1999; 37(9-10):985-92. PubMed ID: 10541455
[TBL] [Abstract][Full Text] [Related]
4. Strong inhibition of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole-induced mutagenesis and hepatocarcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone.
Hirose M; Akagi K; Hasegawa R; Satoh T; Nihro Y; Miki T; Sugimura T; Ito N
Jpn J Cancer Res; 1993 May; 84(5):481-4. PubMed ID: 8320163
[TBL] [Abstract][Full Text] [Related]
5. Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-p-1).
Hirose M; Iwata S; Ito E; Nihro Y; Takahashi S; Mizoguchi Y; Miki T; Satoh T; Ito N; Shirai T
Carcinogenesis; 1995 Sep; 16(9):2227-32. PubMed ID: 7554080
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats.
Hirose M; Takahashi S; Ogawa K; Futakuchi M; Shirai T; Shibutani M; Uneyama C; Toyoda K; Iwata H
Cancer Lett; 1999 Sep; 143(2):173-8. PubMed ID: 10503899
[TBL] [Abstract][Full Text] [Related]
7. Prevention by synthetic phenolic antioxidants of 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)- or activated MeIQx-induced mutagenesis and MeIQx-induced rat hepatocarcinogenesis, and role of antioxidant activity in the prevention of carcinogenesis.
Hirose M; Ito T; Takahashi S; Ozaki M; Ogiso T; Nihro Y; Miki T; Shirai T
Eur J Cancer Prev; 1998 Jun; 7(3):233-41. PubMed ID: 9696932
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats.
Hirose M; Akagi K; Hasegawa R; Yaono M; Satoh T; Hara Y; Wakabayashi K; Ito N
Carcinogenesis; 1995 Feb; 16(2):217-21. PubMed ID: 7859351
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives.
Futakuchi M; Hirose M; Miki T; Tanaka H; Ozaki M; Shirai T
Eur J Cancer Prev; 1998 Apr; 7(2):153-9. PubMed ID: 9818778
[TBL] [Abstract][Full Text] [Related]
10. Modifying effects of chitin, chitosan and their related compounds on 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in a rat medium-term hepatocarcinogenesis model, and their post-initiation effects in a female rat 2-stage multi-organ carcinogenesis model.
Kawabe M; Futakuchi M; Tamano S; Shirai T; Hirose M
Food Chem Toxicol; 2008 Aug; 46(8):2758-63. PubMed ID: 18547703
[TBL] [Abstract][Full Text] [Related]
11. Stage and organ dependent effects of 1-O-hexyl-2,3,5-trimethylhydroquinone, ascorbic acid derivatives, n-heptadecane-8-10-dione and phenylethyl isothiocyanate in a rat multiorgan carcinogenesis model.
Ogawa K; Futakuchi M; Hirose M; Boonyaphiphat P; Mizoguchi Y; Miki T; Shirai T
Int J Cancer; 1998 Jun; 76(6):851-6. PubMed ID: 9626352
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats.
Hirose M; Nishikawa A; Shibutani M; Imai T; Shirai T
Environ Mol Mutagen; 2002; 39(2-3):271-8. PubMed ID: 11921198
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced CYP1A2 expression is associated with bovine lactoferrin inhibition of MeIQx-induced liver and colon carcinogenesis in rats.
Fujita K; Ohnishi T; Sekine K; Iigo M; Tsuda H
Jpn J Cancer Res; 2002 Jun; 93(6):616-25. PubMed ID: 12079509
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat.
Matsumoto N; Kohri T; Okushio K; Hara Y
Jpn J Cancer Res; 1996 Oct; 87(10):1034-8. PubMed ID: 8957060
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
Ito N; Hasegawa R; Shirai T; Fukushima S; Hakoi K; Takaba K; Iwasaki S; Wakabayashi K; Nagao M; Sugimura T
Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine-induced colon carcinogenesis by 1-O-hexyl-2,3,5-trimethylhydroquinone after initiation with 1,2-dimethylhydrazine in F344 rats.
Futakuchi M; Hirose M; Imaida K; Takahashi S; Ogawa K; Asamoto M; Miki T; Shirai T
Carcinogenesis; 2002 Feb; 23(2):283-7. PubMed ID: 11872633
[TBL] [Abstract][Full Text] [Related]
17. Synergistic enhancement of hepatic foci development by combined treatment of rats with 10 heterocyclic amines at low doses.
Hasegawa R; Miyata E; Futakuchi M; Hagiwara A; Nagao M; Sugimura T; Ito N
Carcinogenesis; 1994 May; 15(5):1037-41. PubMed ID: 8200065
[TBL] [Abstract][Full Text] [Related]
18. Dose dependence of 1-O-hexyl-2,3,5-trimethylhydroquinone promotion of forestomach carcinogenesis in rats pretreated with N-ethylnitrosourethane.
Mizoguchi Y; Hirose M; Yamaguchi T; Boonyaphiphat P; Miki T; Shirai T
Jpn J Cancer Res; 1998 May; 89(5):475-80. PubMed ID: 9685849
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations in HCA-induced tumors.
Ushijima T; Makino H; Kakiuchi H; Inoue R; Sugimura T; Nagao M
Princess Takamatsu Symp; 1995; 23():281-91. PubMed ID: 8844820
[TBL] [Abstract][Full Text] [Related]
20. Analysis of synergism in hepatocarcinogenesis based on preneoplastic foci induction by 10 heterocyclic amines in the rat.
Hasegawa R; Yoshimura I; Imaida K; Ito N; Shirai T
Jpn J Cancer Res; 1996 Nov; 87(11):1125-33. PubMed ID: 9045941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
